Clinical trials
Terminated Phase 1/2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
113 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 14 |
| 2021 | 25 |
| 2022 | 18 |
| 2023 | 10 |
| 2024 | 4 |
| 2025 | 8 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 113 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shenzhen Geno-Immune Medical Institute | 19 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 9 |
| Innovent Biologics (Suzhou) Co. Ltd. | 5 |
| Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 5 |
| Akeso | 4 |
| Children's Hospital of Fudan University | 3 |
| Sunshine Lake Pharma Co., Ltd. | 3 |
| Suzhou Junjing BioSciences Co., Ltd. | 3 |
| Antengene Corporation | 2 |
| Ascentage Pharma Group Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Nasopharyngeal Carcinoma | 5 |
| Recurrence | 5 |
| Uterine Cervical Neoplasms | 5 |
| Carcinoma, Hepatocellular | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Ovarian Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Leukemia, Myeloid, Acute | 3 |
Trials
Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.
13 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.